4 Výsledek
FIELD OF INVENTION
The invention relates to novel phosphorylation sites in cardiac troponin I, a protein associated with patient risk stratification and the development of heart failure.
BACKGROUND INFORMATION
Despite continuous efforts to find new effective therapies, heart failure (HF) remains one
BACKGROUND OF THE DISCLOSURE
Heart failure (HF) is among the leading causes of morbidity and mortality in many countries worldwide. Apart from Ivabradine and Cardiac Resynchronization Therapy (CRT), there have been no novel therapies for heart failure in the past years. In contrast, most drug
This is a National Stage Entry of Application No. PCT/IB01/01181 filed Jun. 28, 2001; the disclosure of which is incorporated herein by reference.
BACKGROUND OF THE INVENTION
The present invention refers to compositions based on amino acids, in particular for oral or parenteral use, suitable for the
FIELD OF THE INVENTION
The present invention relates to inhibition of growth factor tyrosine kinase receptor activity, particularly inhibition of angiogenesis and related disorders, tumor progression and growth factor related skeletal disorders, by porphyrin and corrole compounds, and to certain